CR Aim #2 - AT1 Receptor Blockade & ACE Inhibition Effect on Humoral Function

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2015 by Mayo Clinic
Sponsor:
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Horng Chen, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT01678794
First received: August 31, 2012
Last updated: December 17, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2017
  Estimated Primary Completion Date: April 2016 (Final data collection date for primary outcome measure)